Autism Clinic for Translational Research, Child Development and Mental Health Team, Brain and Mind Centre, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia.
Autism Clinic for Translational Research, Child Development and Mental Health Team, Brain and Mind Centre, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia; Clinical Research Unit, Brain and Mind Centre, University of Sydney, Camperdown, NSW 2050, Australia.
Psychiatry Res. 2020 Sep;291:113300. doi: 10.1016/j.psychres.2020.113300. Epub 2020 Jul 13.
The purpose of the study was to examine the internal consistency and validity of the 21-item Depression Anxiety Stress Scale (DASS-21) in individuals with Autism Spectrum Disorder (ASD) and without intellectual disability (IQ >= 70). Participants (NN = 123) were consecutively recruited from the Brain and Mind Centre in New South Wales, Australia. Internal consistency was determined using Cronbach's alpha. Item-total correlations were evaluated by Pearson's product-moment correlation coefficient. The convergent validity of the DASS-21 was examined by measuring its associations with quality of life and other measures of depression and anxiety. Factorial validity was assessed using confirmatory factor analysis. The DASS-21 demonstrated good internal consistency, adequate convergent validity, and all items exhibited satisfactory item-total correlations. Considering fit indices and factor loadings, the confirmatory factor analysis results provided support for the original 3-factor oblique model consisting of depression, anxiety, and stress factors. The model fit could be further improved with some modifications. Overall, the results indicate that the DASS-21 is a viable self-report screening measure for depression, anxiety, and stress in individuals with ASD and without intellectual disability.
本研究旨在检验自闭症谱系障碍(ASD)个体中 21 项抑郁焦虑压力量表(DASS-21)的内部一致性和有效性,这些个体无智力障碍(智商>=70)。参与者(NN=123)连续从澳大利亚新南威尔士州的大脑与思维中心招募。采用 Cronbach 的 alpha 来确定内部一致性。通过 Pearson 积矩相关系数评估项目与总分的相关性。通过测量与生活质量以及其他抑郁和焦虑测量的相关性,来检验 DASS-21 的收敛有效性。使用验证性因子分析评估因子有效性。DASS-21 表现出良好的内部一致性、足够的收敛有效性,并且所有项目都表现出令人满意的项目与总分的相关性。考虑到拟合指数和因子载荷,验证性因子分析结果支持由抑郁、焦虑和压力因素组成的原始 3 因子斜交模型。通过一些修改,可以进一步提高模型拟合度。总的来说,结果表明 DASS-21 是一种可行的自闭症谱系障碍个体中无智力障碍的抑郁、焦虑和压力的自我报告筛查测量工具。